$16.10
At close: Apr 30 EDT
$16.10
0.000.00%
Pre-Market: 4:30 PM EDT
Comments
Loading...
XP Analyst Ratings and Price Targets | NASDAQ:XP | Benzinga
XP Inc has a consensus price target of $22.22 based on the ratings of 9 analysts. The high is $32 issued by Banco Bradesco BBI S.A on January 24, 2024. The low is $13 issued by Goldman Sachs on January 27, 2025. The 3 most-recent analyst ratings were released by Goldman Sachs, UBS, and B of A Securities on January 27, 2025, January 24, 2025, and December 10, 2024, respectively. With an average price target of $15 between Goldman Sachs, UBS, and B of A Securities, there's an implied -6.83% downside for XP Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
UBS
B of A Securities
Morgan Stanley
JP Morgan
1calculated from analyst ratings
Analyst Ratings for XP
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 01/27/2025 | Buy Now | -19.25% | Goldman Sachs | Tito Labarta57% | $19 → $13 | Maintains | Neutral | Get Alert |
| 01/24/2025 | Buy Now | -0.62% | UBS | Thiago Batista66% | $19 → $16 | Upgrade | Neutral → Buy | Get Alert |
| 12/10/2024 | Buy Now | -0.62% | B of A Securities | Mario Pierry50% | $25 → $16 | Downgrade | Buy → Neutral | Get Alert |
| 11/26/2024 | Buy Now | 30.43% | Morgan Stanley | Jorge Kuri32% | $24 → $21 | Maintains | Equal-Weight | Get Alert |
| 10/16/2024 | Buy Now | 80.12% | JP Morgan | Domingos Falavina40% | $28 → $29 | Maintains | Overweight | Get Alert |
| 07/30/2024 | Buy Now | 18.01% | Goldman Sachs | Tito Labarta57% | $22 → $19 | Maintains | Neutral | Get Alert |
| 07/11/2024 | Buy Now | 30.43% | UBS | Thiago Batista66% | $30 → $21 | Downgrade | Buy → Neutral | Get Alert |
| 06/17/2024 | Buy Now | 55.28% | B of A Securities | Mario Pierry50% | $31 → $25 | Maintains | Buy | Get Alert |
| 06/05/2024 | Buy Now | 67.7% | Citigroup | Gabriel Gusan60% | $29 → $27 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | 42.86% | Goldman Sachs | Tito Labarta57% | $30 → $23 | Downgrade | Buy → Neutral | Get Alert |
| 04/23/2024 | Buy Now | 49.07% | Morgan Stanley | Jorge Kuri32% | $31 → $24 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/22/2024 | Buy Now | 80.12% | Citigroup | Gabriel Gusan60% | $28 → $29 | Maintains | Buy | Get Alert |
| 01/24/2024 | Buy Now | 98.76% | Banco Bradesco BBI S.A | Otavio Tanganelli25% | → $32 | Upgrade | Neutral → Outperform | Get Alert |
| 12/05/2023 | Buy Now | 86.34% | JP Morgan | Domingos Falavina40% | $27 → $30 | Upgrade | Neutral → Overweight | Get Alert |
| 09/01/2023 | Buy Now | 104.97% | UBS | Thiago Batista66% | $28 → $33 | Maintains | Buy | Get Alert |
| 08/23/2023 | Buy Now | 67.7% | JP Morgan | Domingos Falavina40% | $18.5 → $27 | Maintains | Neutral | Get Alert |
| 08/21/2023 | Buy Now | 86.34% | Citigroup | Gabriel Gusan60% | $20 → $30 | Maintains | Buy | Get Alert |
| 07/20/2023 | Buy Now | 61.49% | Credit Suisse | Marcelo Telles30% | $15 → $26 | Upgrade | Underperform → Neutral | Get Alert |
| 07/10/2023 | Buy Now | 80.12% | Goldman Sachs | Tito Labarta57% | $22 → $29 | Maintains | Buy | Get Alert |
| 06/22/2023 | Buy Now | — | B of A Securities | Mario Pierry50% | — | Upgrade | Neutral → Buy | Get Alert |
| 05/18/2023 | Buy Now | 5.59% | Banco Bradesco BBI S.A | Otavio Tanganelli25% | $25 → $17 | Downgrade | Outperform → Neutral | Get Alert |
| 05/16/2023 | Buy Now | 36.65% | Goldman Sachs | Tito Labarta57% | $20 → $22 | Maintains | Buy | Get Alert |
| 03/31/2023 | Buy Now | 30.43% | UBS | Thiago Batista66% | $28 → $21 | Maintains | Buy | Get Alert |
| 03/02/2023 | Buy Now | 24.22% | Goldman Sachs | Tito Labarta57% | $30 → $20 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 24.22% | HSBC | Neha Agarwala43% | $26 → $20 | Maintains | Buy | Get Alert |
| 02/27/2023 | Buy Now | 18.01% | Citigroup | Gabriel Gusan60% | $24 → $19 | Maintains | Buy | Get Alert |
| 02/17/2023 | Buy Now | -6.83% | Credit Suisse | Marcelo Telles30% | $27 → $15 | Downgrade | Neutral → Underperform | Get Alert |
| 01/18/2023 | Buy Now | 86.34% | Goldman Sachs | Tito Labarta57% | $35 → $30 | Maintains | Buy | Get Alert |
| 11/28/2022 | Buy Now | 117.39% | Goldman Sachs | Tito Labarta57% | $40 → $35 | Maintains | Buy | Get Alert |
| 10/13/2022 | Buy Now | 148.45% | Goldman Sachs | Tito Labarta57% | $46 → $40 | Maintains | Buy | Get Alert |
| 08/16/2022 | Buy Now | 148.45% | Goldman Sachs | Tito Labarta57% | $46 → $40 | Maintains | Buy | Get Alert |
| 08/11/2022 | Buy Now | 42.86% | JP Morgan | Domingos Falavina40% | → $23 | Downgrade | Overweight → Neutral | Get Alert |
| 06/07/2022 | Buy Now | 92.55% | UBS | Thiago Batista66% | $37 → $31 | Upgrade | Neutral → Buy | Get Alert |
FAQ
What is the target price for XP (XP) stock?
The latest price target for XP (NASDAQ:XP) was reported by Goldman Sachs on January 27, 2025. The analyst firm set a price target for $13.00 expecting XP to fall to within 12 months (a possible -19.25% downside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for XP (XP)?
The latest analyst rating for XP (NASDAQ:XP) was provided by Goldman Sachs, and XP maintained their neutral rating.
When was the last upgrade for XP (XP)?
The last upgrade for XP Inc happened on January 24, 2025 when UBS raised their price target to $16. UBS previously had a neutral for XP Inc.
When was the last downgrade for XP (XP)?
The last downgrade for XP Inc happened on December 10, 2024 when B of A Securities changed their price target from $25 to $16 for XP Inc.
When is the next analyst rating going to be posted or updated for XP (XP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of XP, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for XP was filed on January 27, 2025 so you should expect the next rating to be made available sometime around January 27, 2026.
Is the Analyst Rating XP (XP) correct?
While ratings are subjective and will change, the latest XP (XP) rating was a maintained with a price target of $19.00 to $13.00. The current price XP (XP) is trading at is $16.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
